The REIT Forum

The REIT Forum

Share this post

The REIT Forum
The REIT Forum
Scott Kennedy's mREIT Earnings Series: Assessing Orchid Island’s Performance For Q1 2024 (Slight Outperformance)
Copy link
Facebook
Email
Notes
More

Scott Kennedy's mREIT Earnings Series: Assessing Orchid Island’s Performance For Q1 2024 (Slight Outperformance)

ColoradoWealthManagementFund's avatar
ColoradoWealthManagementFund
Apr 11, 2024
∙ Paid
3

Share this post

The REIT Forum
The REIT Forum
Scott Kennedy's mREIT Earnings Series: Assessing Orchid Island’s Performance For Q1 2024 (Slight Outperformance)
Copy link
Facebook
Email
Notes
More
Share

Summary

  • This earnings assessment article reviews ORC’s BV and core earnings equivalent performance during Q1 2024 and compares results to my expectations. Earnings remain a key driver to stock performance.

  • ORC’s BV slightly exceeded my/our expectations (within range) while its core earnings equivalent was a minor-modest outperformance. No noteworthy surprises.

  • No change in ORC’s percentage recommendation ranges or risk/performance rating. ORC is currently deemed appropriately valued (HOLD). A modest-notable pullback would first need to occur prior to considering a purchase.

  • ORC’s quarterly relatively unchanged BV fluctuation will likely be similar to most sub-sector peers. I want to see continued improvement in ORC’s core earnings equivalent metric prior to an upgrade.

Formatting Change to this Article Series

  • We have recently changed the format of this earnings-related article series (less wording, more visual images). This process remains ongoing and future changes will likely occur.

Commentary

  • Quarterly BV Fluctuation: Minor (Nearly Modest) Outperformance.

  • Net Spread Less Operational Expenses (Core Earnings Equivalent): Minor - Modest Outperformance.

A bit of an encouraging quarter on both metrics for Orchid Island Capital (ORC) ORC 0.00%↑ in my opinion. ORC “eked out” a very minor quarterly BV gain while the company’s core earnings equivalent metric continued to slightly improve. ORC’s minor BV outperformance mainly stemmed from a slightly less severe decrease in the weighted average price decline of the company’s fixed-rate agency MBS sub-portfolio ((1.42) price decline versus my projection of (1.60)). In addition, a likely very minor outperformance within ORC’s derivative instruments valuation fluctuations. ORC’s quarterly core earnings equivalent improvement/outperformance was mainly due to a slightly more favorable decrease in the company’s weighted average repurchase agreement rate versus expectations. ORC’s very minor quarterly conditional/constant prepayment rate (“CPR”) increase was as anticipated. However, nothing “shell shocking” regarding ORC’s quarterly outperformance. As such, I don’t anticipate a performance/risk rating upgrade for ORC at this time. A risk/performance rating of 4.5 for ORC remains appropriate in the current environment/over the foreseeable future (“higher-for-longer” regarding rates/yields).

Change or Maintain

  • BV/NAV Adjustment (BV/NAV Used Interchangeably): Our projection for current BV/NAV per share was adjusted: Up $0.15 (To Account for the Actual 3/31/2024 BV/NAV Vs. Prior Projection). Price targets have already been adjusted to reflect the change in BV/NAV. The update is included in the card below and the subscriber spreadsheets.

  • Percentage Recommendation Range (Relative to CURRENT BV/NAV): No Change.

  • Risk Rating: No Change. Remains at 4.5.

Earnings Results

Note: BV at the end of the quarter. Subscriber spreadsheets and targets use current estimates, not trailing values.

Valuation

Peer Earnings Comparison

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 ColoradoWealthManagementFund
Market data by Intrinio
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More